Technology Prognosis

tracking technologies before you have to make a decision

Tecentriq (Atezolizumab) for Non-Small Cell Lung Cancer

February 8, 2017

A programmed death-ligand 1 checkpoint inhibitor to treat locally advanced or metastatic non-small cell lung cancer.